These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment. Tsunoda K; Yamashita T; Osakada Y; Sasaki R; Tadokoro K; Matsumoto N; Nomura E; Morihara R; Nakano Y; Takahashi Y; Hatanaka N; Shang J; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K J Alzheimers Dis; 2020; 73(1):209-215. PubMed ID: 31771056 [TBL] [Abstract][Full Text] [Related]
3. Clinical features of incidental mild cognitive impairment and dementia in a population-based study. Hishikawa N; Fukui Y; Sato K; Yamashita T; Ohta Y; Abe K Geriatr Gerontol Int; 2017 May; 17(5):722-729. PubMed ID: 27150587 [TBL] [Abstract][Full Text] [Related]
4. Utility of the Spanish version of the Everyday Cognition scale in the diagnosis of mild cognitive impairment and mild dementia in an older cohort from the Argentina-ADNI. Russo MJ; Cohen G; Chrem Mendez P; Campos J; Martín ME; Clarens MF; Tapajoz F; Harris P; Sevlever G; Allegri RF Aging Clin Exp Res; 2018 Oct; 30(10):1167-1176. PubMed ID: 29380265 [TBL] [Abstract][Full Text] [Related]
5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
6. Female dominant association of sarcopenia and physical frailty in mild cognitive impairment and Alzheimer's disease. Ohta Y; Nomura E; Hatanaka N; Osakada Y; Matsumoto N; Sasaki R; Tsunoda K; Takemoto M; Tadokoro K; Hishikawa N; Wakutani Y; Yamashita T; Sato K; Omote Y; Abe K J Clin Neurosci; 2019 Dec; 70():96-101. PubMed ID: 31444048 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous assessment of cognitive and affective functions in multiple system atrophy and cortical cerebellar atrophy in relation to computerized touch-panel screening tests. Kawahara Y; Ikeda Y; Deguchi K; Kurata T; Hishikawa N; Sato K; Kono S; Yunoki T; Omote Y; Yamashita T; Abe K J Neurol Sci; 2015 Apr; 351(1-2):24-30. PubMed ID: 25727351 [TBL] [Abstract][Full Text] [Related]
8. The clock drawing test as a screening tool in mild cognitive impairment and very mild dementia: a new brief method of scoring and normative data in the elderly. Ricci M; Pigliautile M; D'Ambrosio V; Ercolani S; Bianchini C; Ruggiero C; Vanacore N; Mecocci P Neurol Sci; 2016 Jun; 37(6):867-73. PubMed ID: 26863871 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory. Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659 [TBL] [Abstract][Full Text] [Related]
10. Triple test, a diagnostic observation, can detect cognitive impairment in older adults. Isik AT; Soysal P; Kaya D; Usarel C Psychogeriatrics; 2018 Mar; 18(2):98-105. PubMed ID: 29409161 [TBL] [Abstract][Full Text] [Related]
11. Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer's disease. Siafarikas N; Selbaek G; Fladby T; Šaltytė Benth J; Auning E; Aarsland D Int Psychogeriatr; 2018 Jan; 30(1):103-113. PubMed ID: 28927477 [TBL] [Abstract][Full Text] [Related]
12. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study. Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740 [TBL] [Abstract][Full Text] [Related]
13. Screening for Mild Cognitive Impairment Using the Dementia Rating Scale-2. Springate BA; Tremont G; Papandonatos G; Ott BR J Geriatr Psychiatry Neurol; 2014 Jun; 27(2):139-44. PubMed ID: 24578462 [TBL] [Abstract][Full Text] [Related]
14. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study. Yoon JH; Kim M; Moon SY; Yong SW; Hong JM J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880 [TBL] [Abstract][Full Text] [Related]
15. Ecological assessment of mild cognitive impairment and Alzheimer disease using the Rivermead Behavioural Memory Test. Bolló-Gasol S; Piñol-Ripoll G; Cejudo-Bolivar JC; Llorente-Vizcaino A; Peraita-Adrados H Neurologia; 2014; 29(6):339-45. PubMed ID: 24139389 [TBL] [Abstract][Full Text] [Related]
16. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536 [TBL] [Abstract][Full Text] [Related]
18. Reliability and validity of A Quick Test of Cognitive Speed for detecting early-stage dementia in elderly Japanese. Takahashi F; Awata S; Sakuma N; Inagaki H; Ijuin M Psychogeriatrics; 2012 Jun; 12(2):75-82. PubMed ID: 22712639 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study. Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684 [TBL] [Abstract][Full Text] [Related]
20. A novel useful tool of computerized touch panel-type screening test for evaluating cognitive function of chronic ischemic stroke patients. Deguchi K; Kono S; Deguchi S; Morimoto N; Kurata T; Ikeda Y; Abe K J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e197-206. PubMed ID: 23290436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]